findmyKOL
Clinical trialNCT05332067RecruitingPhase 2Interventional

Omalizumab Before Onset of Exacerbations

SponsorChildren's National Research InstituteEnrollment300Asthma in ChildrenAtopyViral Upper Respiratory Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S National Hospital

    Washington D.C., District of Columbia, United States

    Deepa Rastogi, MBBS, MSRobert Freishtat, MD, MPHShilpa Patel, MD, MPHWilliam Sheehan, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2022
Primary completion
1 Jan 2028
Completion
1 Mar 2028
Last update posted
14 Jul 2025
Registered enrollment
300
Registry id
NCT05332067
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.